Exact Mass: 313.1552

Exact Mass Matches: 313.1552

Found 55 metabolites which its exact mass value is equals to given mass value 313.1552, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

3,4-dimethylidenehexanedioylcarnitine

3-[(5-carboxy-3,4-dimethylidenepentanoyl)oxy]-4-(trimethylazaniumyl)butanoate

C15H23NO6 (313.1525)


3,4-dimethylidenehexanedioylcarnitine is an acylcarnitine. More specifically, it is an 3,4-dimethylidenehexanedioic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 3,4-dimethylidenehexanedioylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine 3,4-dimethylidenehexanedioylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

Octa-3,5-dienedioylcarnitine

3-[(7-Carboxyhepta-3,5-dienoyl)oxy]-4-(trimethylazaniumyl)butanoic acid

C15H23NO6 (313.1525)


Octa-3,5-dienedioylcarnitine is an acylcarnitine. More specifically, it is an octa-3,5-dienedioic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. octa-3,5-dienedioylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine octa-3,5-dienedioylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

Octa-2,6-dienedioylcarnitine

3-[(7-Carboxyhepta-2,6-dienoyl)oxy]-4-(trimethylazaniumyl)butanoic acid

C15H23NO6 (313.1525)


Octa-2,6-dienedioylcarnitine is an acylcarnitine. More specifically, it is an octa-2,6-dienedioic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. octa-2,6-dienedioylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine octa-2,6-dienedioylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

(2Z,4Z)-Octa-2,4-dienedioylcarnitine

(2Z,4Z)-Octa-2,4-dienedioylcarnitine

C15H23NO6 (313.1525)


(2Z,4Z)-octa-2,4-dienedioylcarnitine is an acylcarnitine. More specifically, it is an (2Z,4Z)-octa-2,4-dienedioic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. (2Z,4Z)-octa-2,4-dienedioylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine (2Z,4Z)-octa-2,4-dienedioylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

Octa-3,6-dienedioylcarnitine

3-[(7-Carboxyhepta-3,6-dienoyl)oxy]-4-(trimethylazaniumyl)butanoic acid

C15H23NO6 (313.1525)


Octa-3,6-dienedioylcarnitine is an acylcarnitine. More specifically, it is an octa-3,6-dienedioic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. octa-3,6-dienedioylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine octa-3,6-dienedioylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

10-(2-(Diethylamino)propyl)-10H-pyrido(3,2-b)(1,4)benzothiazine

diethyl(1-{9-thia-2,4-diazatricyclo[8.4.0.0^{3,8}]tetradeca-1(14),3(8),4,6,10,12-hexaen-2-yl}propan-2-yl)amine

C18H23N3S (313.1613)


   

Sematilide

N-[2-(Diethylamino)ethyl]-4-methanesulphonamidobenzamide

C14H23N3O3S (313.146)


   

SESBANIMIDE C

SESBANIMIDE C

C15H23NO6 (313.1525)


   

209414-06-2

209414-06-2

C22H19NO (313.1467)


   
   

1-ethenamino-7-(5-oxohex-1-ynyl)phenanthrene

1-ethenamino-7-(5-oxohex-1-ynyl)phenanthrene

C22H19NO (313.1467)


   
   

MaprotilineHCl

MaprotilineHCl

C20H24ClN (313.1597)


   

Maprotiline Hydrochloride

Maprotiline Hydrochloride

C20H24ClN (313.1597)


D018377 - Neurotransmitter Agents > D014179 - Neurotransmitter Uptake Inhibitors > D018759 - Adrenergic Uptake Inhibitors C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent > C94727 - Tricyclic Antidepressant D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D000928 - Antidepressive Agents D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents D049990 - Membrane Transport Modulators

   

amitriptyline

amitriptyline

C20H24ClN (313.1597)


   
   
   
   
   

4-[5-(4-butylphenyl)pyrimidin-2-yl]benzonitrile

4-[5-(4-butylphenyl)pyrimidin-2-yl]benzonitrile

C21H19N3 (313.1579)


   

N-Desmethylterbinafine hydrochloride

N-Desmethylterbinafine hydrochloride

C20H24ClN (313.1597)


   

Sematilide

Sematilide

C14H23N3O3S (313.146)


C78274 - Agent Affecting Cardiovascular System > C47793 - Antiarrhythmic Agent D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents

   

3-AMINO-N,N-DIETHYL-4-MORPHOLIN-4-YL-BENZENESULFONAMIDE

3-AMINO-N,N-DIETHYL-4-MORPHOLIN-4-YL-BENZENESULFONAMIDE

C14H23N3O3S (313.146)


   

tert-butyl 4-(4-amino-2,6-difluorophenyl)piperazine-1-carboxylate

tert-butyl 4-(4-amino-2,6-difluorophenyl)piperazine-1-carboxylate

C15H21F2N3O2 (313.1602)


   

Ethyl 2-amino-4,5-bis(2-methoxyethoxy)benzoate

Ethyl 2-amino-4,5-bis(2-methoxyethoxy)benzoate

C15H23NO6 (313.1525)


   

1-Naphthyl(1-propyl-1H-indol-3-yl)methanone

1-Naphthyl(1-propyl-1H-indol-3-yl)methanone

C22H19NO (313.1467)


   

N-[2-Isopropylthiazol-4-ylmethyl(methyl)carbamoyl]-L-valine

N-[2-Isopropylthiazol-4-ylmethyl(methyl)carbamoyl]-L-valine

C14H23N3O3S (313.146)


   

(4R)-2-Methyl-4,5,5-triphenyl-1,3,2-oxazaborolidine

(4R)-2-Methyl-4,5,5-triphenyl-1,3,2-oxazaborolidine

C21H20BNO (313.1638)


   

P-TOLYLTETRAZOLIUM RED

P-TOLYLTETRAZOLIUM RED

C20H17N4+ (313.1453)


   

Acecainide hydrochloride

N-AcetylprocainaMide hydrochloride

C15H24ClN3O2 (313.1557)


C78274 - Agent Affecting Cardiovascular System > C47793 - Antiarrhythmic Agent D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents C93038 - Cation Channel Blocker

   

4-Benzyloxy-2-piperidine-1-yl-pyrimidine-5-boronic acid

4-Benzyloxy-2-piperidine-1-yl-pyrimidine-5-boronic acid

C16H20BN3O3 (313.1598)


   

Amitriptyline Hydrochloride

Amitriptyline Hydrochloride

C20H24ClN (313.1597)


D018377 - Neurotransmitter Agents > D014179 - Neurotransmitter Uptake Inhibitors > D018759 - Adrenergic Uptake Inhibitors C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent > C94727 - Tricyclic Antidepressant D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D000928 - Antidepressive Agents D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D049990 - Membrane Transport Modulators Amitriptyline hydrochloride is an inhibitor of serotonin reuptake transporter (SERT) and noradrenaline reuptake transporter (NET), with Kis of 3.45 nM and 13.3 nM for human SERT and NET, respectively. Amitriptyline hydrochloride also weakly binds to dopamine reuptake transporter (DAT) with a Ki of 2.58 μM. Amitriptyline hydrochloride also inhibits adrenergic, muscarinic, histamine and 5-HT receptors. Amitriptyline hydrochloride is a TrkA and TrkB receptors agonist with potent neurotrophic activity. Amitriptyline hydrochloride has antidepressant activity[1][2][3].

   
   

7,8-Dihydro-6-hydroxymethyl-7-methyl-7-[2-phenylethyl]-pterin

7,8-Dihydro-6-hydroxymethyl-7-methyl-7-[2-phenylethyl]-pterin

C16H19N5O2 (313.1539)


   

1-isopropyl-3-(3,4-dimethoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine

1-isopropyl-3-(3,4-dimethoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine

C16H19N5O2 (313.1539)


   

(2S)-2-[(E)-[(2S)-2-amino-3-(4-hydroxyphenyl)propylidene]amino]-3-(4-hydroxyphenyl)propanal

(2S)-2-[(E)-[(2S)-2-amino-3-(4-hydroxyphenyl)propylidene]amino]-3-(4-hydroxyphenyl)propanal

C18H21N2O3+ (313.1552)


   

5-Ethyl-3-imino-6-phenyl-phenanthridin-8-amine

5-Ethyl-3-imino-6-phenyl-phenanthridin-8-amine

C21H19N3 (313.1579)


   

(2S)-2-[[(2E,6E)-7-carboxy-3-methylocta-2,6-dienyl]amino]pentanedioic acid

(2S)-2-[[(2E,6E)-7-carboxy-3-methylocta-2,6-dienyl]amino]pentanedioic acid

C15H23NO6 (313.1525)


   

3,4-dimethylidenehexanedioylcarnitine

3,4-dimethylidenehexanedioylcarnitine

C15H23NO6 (313.1525)


   

Octa-3,5-dienedioylcarnitine

Octa-3,5-dienedioylcarnitine

C15H23NO6 (313.1525)


   

Octa-2,6-dienedioylcarnitine

Octa-2,6-dienedioylcarnitine

C15H23NO6 (313.1525)


   

Octa-3,6-dienedioylcarnitine

Octa-3,6-dienedioylcarnitine

C15H23NO6 (313.1525)


   

(2Z,4Z)-Octa-2,4-dienedioylcarnitine

(2Z,4Z)-Octa-2,4-dienedioylcarnitine

C15H23NO6 (313.1525)


   

N,N-dimethyl-3-[(2-phenyl-6,7-dihydro-5H-cyclopenta[d]pyrimidin-4-yl)thio]-1-propanamine

N,N-dimethyl-3-[(2-phenyl-6,7-dihydro-5H-cyclopenta[d]pyrimidin-4-yl)thio]-1-propanamine

C18H23N3S (313.1613)


   

1-(2-Fluorophenyl)-3-[2-(1-piperidinyl)phenyl]urea

1-(2-Fluorophenyl)-3-[2-(1-piperidinyl)phenyl]urea

C18H20FN3O (313.159)


   

1-(4-Fluorophenyl)-3-(4-morpholinyl)-2-phenyl-1-propanone

1-(4-Fluorophenyl)-3-(4-morpholinyl)-2-phenyl-1-propanone

C19H20FNO2 (313.1478)


   
   
   
   
   

1-(3-Fluorophenyl)-3-(4-morpholinyl)-2-phenyl-1-propanone

1-(3-Fluorophenyl)-3-(4-morpholinyl)-2-phenyl-1-propanone

C19H20FNO2 (313.1478)


   

1-(2-Fluorophenyl)-3-(4-morpholinyl)-2-phenyl-1-propanone

1-(2-Fluorophenyl)-3-(4-morpholinyl)-2-phenyl-1-propanone

C19H20FNO2 (313.1478)


   

1- [α-(1- adamantyl)]- phenyl thiosemicarbazide

NA

C18H23N3S (313.1613)


{"Ingredient_id": "HBIN002265","Ingredient_name": "1- [\u03b1-(1- adamantyl)]- phenyl thiosemicarbazide","Alias": "NA","Ingredient_formula": "C18H23N3S","Ingredient_Smile": "C1C2CC3CC1CC(C2)(C3)C(=NNC(=S)N)C4=CC=CC=C4","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "35120","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

6-hydroxy-4-[(2r,3r)-2-hydroxy-3-[(2s,3s)-2-hydroxy-3-methyl-4-methylideneoxolan-2-yl]-3-methoxypropyl]-4,5-dihydro-3h-pyridin-2-one

6-hydroxy-4-[(2r,3r)-2-hydroxy-3-[(2s,3s)-2-hydroxy-3-methyl-4-methylideneoxolan-2-yl]-3-methoxypropyl]-4,5-dihydro-3h-pyridin-2-one

C15H23NO6 (313.1525)


   

6-hydroxy-4-[2-hydroxy-3-(2-hydroxy-3-methyl-4-methylideneoxolan-2-yl)-3-methoxypropyl]-4,5-dihydro-3h-pyridin-2-one

6-hydroxy-4-[2-hydroxy-3-(2-hydroxy-3-methyl-4-methylideneoxolan-2-yl)-3-methoxypropyl]-4,5-dihydro-3h-pyridin-2-one

C15H23NO6 (313.1525)